Bioplus Acquisition Corp Stock Number Of Employees
BioPlus Acquisition Corp fundamentals help investors to digest information that contributes to BioPlus Acquisition's financial success or failures. It also enables traders to predict the movement of BioPlus Stock. The fundamental analysis module provides a way to measure BioPlus Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioPlus Acquisition stock.
BioPlus |
BioPlus Acquisition Corp Company Number Of Employees Analysis
BioPlus Acquisition's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current BioPlus Acquisition Number Of Employees | 38 |
Most of BioPlus Acquisition's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioPlus Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, BioPlus Acquisition Corp is currently employing 38.0 people. This is 99.77% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The number of employees for all United States stocks is 99.8% higher than that of the company.
BioPlus Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioPlus Acquisition's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioPlus Acquisition could also be used in its relative valuation, which is a method of valuing BioPlus Acquisition by comparing valuation metrics of similar companies.BioPlus Acquisition is currently under evaluation in number of employees category among its peers.
BioPlus Fundamentals
| Return On Asset | -0.0072 | |||
| Current Valuation | 215.16 M | |||
| Shares Outstanding | 19.37 M | |||
| Shares Owned By Insiders | 48.69 % | |||
| Shares Owned By Institutions | 51.31 % | |||
| Number Of Shares Shorted | 1.64 K | |||
| Price To Earning | (3.62) X | |||
| EBITDA | (1.17 M) | |||
| Net Income | 2 M | |||
| Cash And Equivalents | 294.69 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5 M | |||
| Debt To Equity | 7.23 % | |||
| Current Ratio | 2.96 X | |||
| Book Value Per Share | (0.86) X | |||
| Cash Flow From Operations | (691.47 K) | |||
| Short Ratio | 0.03 X | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | (7.93) X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 38 | |||
| Beta | 0.14 | |||
| Market Capitalization | 208.98 M | |||
| Total Asset | 238.32 M | |||
| Retained Earnings | (14.78 M) | |||
| Working Capital | 21.89 K | |||
| Current Asset | 183.69 M | |||
| Current Liabilities | 152.76 M | |||
| Z Score | 24.97 | |||
| Net Asset | 238.32 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |